Checkout
Cart: £0.00 - (0 items )

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking vaccine in 90 percent of participants in its Phase 3 clinical trial, the companies announced on Monday. That’s based on data analyzed by an […]

Read More

Alphabet’s X details Project Amber, a quest for a single biomarker for depression that fell short of its goal

Alphabet’s X details Project Amber, a quest for a single biomarker for depression that fell short of its goal Alphabet’s X (the Google-owner’s so-called ‘Moonshot Factory’) published a new blog post today about Project Amber, a project it’s been working on over the past three years – the results of which it’s now making available […]

Read More

Lawmakers Demand Scrutiny of Racial Bias in Health Algorithms

Lawmakers Demand Scrutiny of Racial Bias in Health Algorithms Four congressmembers say formulas that include race as a factor can hurt Black Americans’ access to care. Source: {$feed_title) Lawmakers Demand Scrutiny of Racial Bias in Health Algorithms

Read More

United Airlines is making COVID-19 tests available to passengers, powered in part by Color

United Airlines is making COVID-19 tests available to passengers, powered in part by Color There’s still no clear path back to any sense of ‘business-as-usual’ as the COVID-19 pandemic continues, but United Airlines is embarking on a new pilot project to see if easy access to COVID-19 testing immediately prior to a flight can help […]

Read More

Daphne Koller: ‘Digital biology is an incredible place to be right now’

Daphne Koller: ‘Digital biology is an incredible place to be right now’ Working at the intersection of biology and computing may be the most exciting new spot for technologists at the moment. That’s the word from Daphne Koller, the founder and chief executive officer of Insitro — the biotech company that’s raised over $243 million […]

Read More

VenoStent has a new technology to improve outcomes for dialysis patients

VenoStent has a new technology to improve outcomes for dialysis patients Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients. Failed dialysis surgeries occur in roughly 55% to […]

Read More

Moderna’s 30,000-participant Phase 3 COVID-19 vaccine trial kicks off in the U.S.

Moderna’s 30,000-participant Phase 3 COVID-19 vaccine trial kicks off in the U.S. The largest trial yet for a potential COVID-19 vaccine began on Monday, as drug company Moderna began providing the first of an anticipated 30,000 volunteers with shots of its candidates. This is a blind trial, wherein some participants will get the vaccine and […]

Read More

IBM Research develops new macromolecule that could counter antibiotic resistance

IBM Research develops new macromolecule that could counter antibiotic resistance There are other persistent, grave health crises brewing besides the ongoing COVID-19 pandemic: Antibiotic resistance is one, and the troubling trend is that it’s on the rise, leading to an increase in so-called ‘superbugs’ that are difficult to treat. IBM Research, working in partnership with […]

Read More

Color’s COVID-19 testing shows most who test positive had either mild or no symptoms

Color’s COVID-19 testing shows most who test positive had either mild or no symptoms Echoing much of the existing data and research on the subject, SF-based Color released data today showing that based on its own testing program, most individuals who test positive for COVID-19 display either mild or no symptoms, including even running a […]

Read More

Moderna set to start final-stage trial of its coronavirus vaccine by July

Moderna set to start final-stage trial of its coronavirus vaccine by July Pharmaceutical company Moderna told Bloomberg on Thursday that it’s on pace to begin the final-stage clinical trial of its vaccine for the novel coronavirus that causes COVID-19 by July. Moderna was the first company to begin human clinical trials of its vaccine candidate […]

Read More

Back to top